Clinical trial
Effect of Migalastat on Cardiac Involvement in Fabry Disease
NCT03838237 is registered in ClinicalTrials.gov with Ospedale San Donato as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Migalastat on Cardiac Involvement in Fabry Disease
- Lead sponsor
- Ospedale San Donato
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 10, 2018
- Completion date
- January 22, 2021
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.